Enveric Biosciences, Inc.
Price Action
Technical Summary
WEAKENINGEnveric Biosciences, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 56), indicating performance broadly in line with the market. Earnings growth of 39% provides fundamental context to the price action. However, price is extended 24% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $3.37 | -5.63% | BELOW |
| 50 SMA | $2.56 | +24.11% | ABOVE |
| 100 SMA | $3.11 | +2.25% | ABOVE |
| 150 SMA | $4.40 | -27.80% | BELOW |
| 200 SMA | $6.41 | -50.40% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ENVB in an uptrend right now?
ENVB has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is ENVB overbought or oversold?
ENVB's RSI (14) is 52. The stock is in neutral territory, neither overbought nor oversold.
Is ENVB outperforming the market?
ENVB has a Relative Strength (RS) Rating of 56 out of 99. ENVB is performing about average compared to the market.
Where is ENVB in its 52-week range?
ENVB is trading at $3.18, which is 18% of its 52-week high ($17.88) and 9% above its 52-week low ($1.71).
How volatile is ENVB?
ENVB has a Beta of 1.99 and 52-week volatility of 141%. It's more volatile than the S&P 500 - expect bigger swings.